| Bioactivity | α-Glucosidase-IN-9 (compound 7) is a potent α-glucosidase inhibitor, with an IC50 of 55.6 μM. α-Glucosidase-IN-9 can be used for type II diabetes research[1]. |
| Target | IC50: 55.6 ± 0.3 μM (α-Glucosidase) |
| Name | α-Glucosidase-IN-9 |
| CAS | 735273-33-3 |
| Formula | C19H12N4OS |
| Molar Mass | 344.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ali M, et al. Synthesis, in vitro and in silico screening of 2-amino-4-aryl-6-(phenylthio) pyridine-3,5-dicarbonitriles as novel α-glucosidase inhibitors. Bioorg Chem. 2020 Jul;100:103879. |
α-Glucosidase-IN-9
CAS: 735273-33-3 F: C19H12N4OS W: 344.39
α-Glucosidase-IN-9 (compound 7) is a potent α-glucosidase inhibitor, with an IC50 of 55.6 μM. α-Glucosidase-IN-9 can
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.